Nifty
:
23063.10
Sensex
:
73580.54
-383.70 (-1.64%)
-1247.71 (-1.67%)
Nifty
Sensex
:
:
23063.10
73580.54
-383.70 (-1.64%)
-1247.71 (-1.67%)

Shree Ganesh Remedies Ltd.

Pharmaceuticals & Drugs

Rating :
60/99

BSE: 540737 | NSE: SGRL

NSE BSE
677.15
24-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  731.5
  •  739.45
  •  654
  •  735.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  45846
  •  32147751.45
  •  749.85
  •  477.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 872.38
  • 56.52
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 889.57
  • N/A
  • 5.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.84%
  • 1.09%
  • 24.63%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.59
  • 8.92
  • -4.61

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.01
  • 14.34
  • -3.48

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.01
  • 5.81
  • -14.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 35.18
  • 36.20

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.73
  • 4.49

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 24.88
  • 26.31

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
14.36
24.67
-41.79%
33.20
24.43
35.90%
21.11
27.05
-21.96%
30.31
32.33
-6.25%
Expenses
11.01
17.37
-36.61%
21.82
14.56
49.86%
14.38
17.15
-16.15%
20.70
21.02
-1.52%
EBITDA
3.35
7.30
-54.11%
11.37
9.88
15.08%
6.73
9.90
-32.02%
9.62
11.31
-14.94%
EBIDTM
23.35%
29.58%
34.27%
40.43%
31.89%
36.59%
31.73%
34.98%
Other Income
0.94
0.66
42.42%
1.02
2.29
-55.46%
0.66
0.71
-7.04%
0.69
0.19
263.16%
Interest
0.32
0.94
-65.96%
0.88
0.97
-9.28%
0.74
0.39
89.74%
1.01
0.44
129.55%
Depreciation
2.44
2.42
0.83%
2.80
2.42
15.70%
2.67
2.70
-1.11%
2.59
2.42
7.02%
PBT
1.53
4.60
-66.74%
8.72
8.77
-0.57%
3.98
7.53
-47.14%
6.71
8.64
-22.34%
Tax
0.41
1.15
-64.35%
2.46
2.18
12.84%
0.89
2.10
-57.62%
1.76
2.23
-21.08%
PAT
1.12
3.45
-67.54%
6.27
6.59
-4.86%
3.09
5.42
-42.99%
4.96
6.41
-22.62%
PATM
7.81%
13.97%
18.88%
26.97%
14.65%
20.05%
16.35%
19.81%
EPS
0.87
2.68
-67.54%
4.88
5.13
-4.87%
2.41
4.22
-42.89%
3.86
4.99
-22.65%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 20
Mar 19
Net Sales
98.98
109.29
108.60
125.90
64.02
35.31
Net Sales Growth
-8.76%
0.64%
-13.74%
96.66%
81.31%
 
Cost Of Goods Sold
35.23
41.88
35.87
57.45
37.92
18.50
Gross Profit
63.75
67.41
72.72
68.45
26.10
16.82
GP Margin
64.40%
61.68%
66.96%
54.37%
40.77%
47.64%
Total Expenditure
67.91
74.27
69.38
84.09
51.50
26.57
Power & Fuel Cost
-
5.77
7.89
6.39
1.54
0.85
% Of Sales
-
5.28%
7.27%
5.08%
2.41%
2.41%
Employee Cost
-
11.40
10.12
8.41
2.90
1.63
% Of Sales
-
10.43%
9.32%
6.68%
4.53%
4.62%
Manufacturing Exp.
-
8.10
7.35
4.82
0.70
0.56
% Of Sales
-
7.41%
6.77%
3.83%
1.09%
1.59%
General & Admin Exp.
-
2.92
2.72
2.48
6.93
3.69
% Of Sales
-
2.67%
2.50%
1.97%
10.82%
10.45%
Selling & Distn. Exp.
-
3.35
4.77
3.95
1.23
1.18
% Of Sales
-
3.07%
4.39%
3.14%
1.92%
3.34%
Miscellaneous Exp.
-
0.86
0.66
0.60
0.28
0.17
% Of Sales
-
0.79%
0.61%
0.48%
0.44%
0.48%
EBITDA
31.07
35.02
39.22
41.81
12.52
8.74
EBITDA Margin
31.39%
32.04%
36.11%
33.21%
19.56%
24.75%
Other Income
3.31
3.03
3.73
3.07
3.91
1.17
Interest
2.95
3.56
2.11
0.61
0.54
0.20
Depreciation
10.50
10.47
9.57
6.11
2.29
1.04
PBT
20.94
24.01
31.27
38.16
13.59
8.67
Tax
5.52
6.25
8.20
10.05
3.12
2.43
Tax Rate
26.36%
26.03%
26.22%
26.34%
22.96%
28.03%
PAT
15.44
17.76
23.07
28.11
10.47
6.24
PAT before Minority Interest
15.44
17.76
23.07
28.11
10.47
6.24
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
15.60%
16.25%
21.24%
22.33%
16.35%
17.67%
PAT Growth
-29.40%
-23.02%
-17.93%
168.48%
67.79%
 
EPS
12.06
13.88
18.02
21.96
8.18
4.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 20
Mar 19
Shareholder's Funds
162.97
145.16
122.10
42.20
33.82
Share Capital
12.84
12.84
12.84
8.97
8.97
Total Reserves
150.13
132.32
109.25
33.23
24.85
Non-Current Liabilities
23.03
30.60
30.16
2.65
0.73
Secured Loans
21.25
29.48
29.12
0.04
0.24
Unsecured Loans
0.00
0.00
0.00
2.15
0.00
Long Term Provisions
0.57
0.46
0.33
0.18
0.16
Current Liabilities
26.78
24.23
25.96
10.38
6.79
Trade Payables
9.44
5.97
8.19
4.52
3.90
Other Current Liabilities
11.64
10.17
8.30
0.20
0.18
Short Term Borrowings
0.02
0.02
0.71
2.07
0.33
Short Term Provisions
5.68
8.07
8.76
3.59
2.39
Total Liabilities
212.78
199.99
178.22
55.27
41.34
Net Block
104.66
95.00
80.55
20.14
14.50
Gross Block
148.07
128.34
105.23
28.81
21.05
Accumulated Depreciation
43.41
33.34
24.68
8.68
6.55
Non Current Assets
121.82
114.37
100.73
21.46
15.53
Capital Work in Progress
12.86
8.78
16.92
0.00
0.00
Non Current Investment
0.08
0.08
0.08
0.07
0.05
Long Term Loans & Adv.
4.19
10.50
3.18
1.06
0.72
Other Non Current Assets
0.04
0.00
0.01
0.20
0.27
Current Assets
90.96
85.62
77.48
33.82
25.81
Current Investments
12.45
18.26
4.66
3.00
4.00
Inventories
24.01
22.02
24.99
6.41
6.51
Sundry Debtors
32.56
22.27
20.33
17.79
9.72
Cash & Bank
13.48
10.03
16.26
2.33
1.00
Other Current Assets
8.45
1.16
0.80
0.00
4.58
Short Term Loans & Adv.
7.27
11.88
10.43
4.29
4.58
Net Current Assets
64.17
61.39
51.52
23.44
19.02
Total Assets
212.78
199.99
178.21
55.28
41.34

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 20
Mar 19
Cash From Operating Activity
23.74
30.66
30.45
4.59
-5.22
PBT
24.01
31.27
38.16
13.59
8.67
Adjustment
11.62
11.18
5.89
-3.66
-0.35
Changes in Working Capital
-7.07
-1.73
-5.47
-5.34
-13.53
Cash after chg. in Working capital
28.57
40.72
38.59
4.59
-5.22
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.82
-10.05
-8.14
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-9.89
-35.66
-33.01
-2.91
-0.08
Net Fixed Assets
-23.81
-14.97
-97.03
-4.07
Net Investments
5.81
-13.60
2.28
-3.05
Others
8.11
-7.09
61.74
4.21
Cash from Financing Activity
-11.70
-1.09
9.84
-0.48
-0.18
Net Cash Inflow / Outflow
2.16
-6.08
7.28
1.20
-5.47
Opening Cash & Equivalents
9.95
15.85
8.66
1.13
6.46
Closing Cash & Equivalent
13.40
9.95
15.85
2.33
0.99

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 20
Mar 19
Book Value (Rs.)
126.95
113.07
95.07
35.14
33.80
ROA
8.61%
12.20%
24.08%
21.67%
15.08%
ROE
11.53%
17.26%
34.22%
27.55%
18.43%
ROCE
14.63%
19.53%
37.81%
34.79%
25.66%
Fixed Asset Turnover
0.80
0.95
1.93
2.57
1.68
Receivable days
90.51
69.81
53.79
78.42
100.48
Inventory Days
75.97
77.02
44.31
36.84
67.29
Payable days
67.15
72.01
40.38
32.14
54.62
Cash Conversion Cycle
99.32
74.82
57.72
83.12
113.16
Total Debt/Equity
0.19
0.26
0.30
0.11
0.02
Interest Cover
7.74
15.84
63.85
26.05
43.45

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.